{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:40:12Z","timestamp":1716252012462},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,20]]},"DOI":"10.7759\/cureus.60708","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:18:31Z","timestamp":1716250711000},"source":"Crossref","is-referenced-by-count":0,"title":["Exploring the Impact of Subclinical Hypothyroidism on Hyperpigmentation: A Rare Presentation in a 42-Year-Old Woman"],"prefix":"10.7759","author":[{"given":"Bracha","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiya","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alia","family":"Silkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013279","article-title":"General hyperpigmentation induced by Grave's disease: a case report","volume":"97","author":"Song X","year":"2018","unstructured":"Song X, Shen Y, Zhou Y, Lou Q, Han L, Ho JK, Ren Y. General hyperpigmentation induced by Grave's disease: a case report. Medicine (Baltimore). 2018, 97:e13279. 10.1097\/MD.0000000000013279","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0239-8","article-title":"Facial hyperpigmentation in skin of color: special considerations and treatment","volume":"18","author":"Vashi NA","year":"2017","unstructured":"Vashi NA, Wirya SA, Inyang M, Kundu RV. Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017, 18:215-30. 10.1007\/s40257-016-0239-8","journal-title":"Am J Clin Dermatol"},{"key":"ref3","article-title":"Cutaneous consequences of accelerated thyroid function","volume":"37","author":"Mullin GE","year":"1986","unstructured":"Mullin GE, Eastern JS. Cutaneous consequences of accelerated thyroid function. Cutis. 1986, 37:109-14.","journal-title":"Cutis"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1210\/jcem-61-1-28","article-title":"Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma","volume":"61","author":"Lutfi RJ","year":"1985","unstructured":"Lutfi RJ, Fridmanis M, Misiunas AL, et al.. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. J Clin Endocrinol Metab. 1985, 61:28-31.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2015.54742","article-title":"Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients","volume":"32","author":"\u00c7akmak SK","year":"2015","unstructured":"\u00c7akmak SK, \u00d6zcan N, K\u0131l\u0131\u00e7 A, Koparal S, Art\u00fcz F, \u00c7akmak A, K\u00f6se K. Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients. Postepy Dermatol Alergol. 2015, 32:327-30. 10.5114\/pdia.2015.54742","journal-title":"Postepy Dermatol Alergol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.257","article-title":"Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations","volume":"48","author":"Ai J","year":"2003","unstructured":"Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol. 2003, 48:641-59; quiz 660-2. 10.1067\/mjd.2003.257","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304050-00003","article-title":"Cutaneous manifestations of endocrine disorders: a guide for dermatologists","volume":"4","author":"Jabbour SA","year":"2003","unstructured":"Jabbour SA. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol. 2003, 4:315-31. 10.2165\/00128071-200304050-00003","journal-title":"Am J Clin Dermatol"},{"key":"ref8","article-title":"Methimazole","author":"Awosika AO","year":"2023","unstructured":"Awosika AO, Singh G, Correa R. Methimazole. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244847-exploring-the-impact-of-subclinical-hypothyroidism-on-hyperpigmentation-a-rare-presentation-in-a-42-year-old-woman","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:18:36Z","timestamp":1716250716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244847-exploring-the-impact-of-subclinical-hypothyroidism-on-hyperpigmentation-a-rare-presentation-in-a-42-year-old-woman"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.60708","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,20]]}}}